ICTA

ICTA | 2,075 followers on LinkedIn. ICTA is an international privately-owned CRO with 32 years of experience in clinical R&D, pharmaco-epidemiology and expanded access programs for APIs, cell therapies, diagnostics and medical devices. ICTA’s international operations in Western/Eastern Europe and the USA provide full clinical research or “a la carte” services in traditional and adaptive clinical trials from Early Phase to Late Phase across a broad range of therapeutic areas. Our active interaction with a high-level international academic network, our adaptive management supported by a powerful secured information system (I-SIT platform) are hallmarks which made of ICTA one of the first few CROs able to design and successfully conduct adaptive and Bayesian clinical trials including seamless studies.